What is WO2010020675A1 and what does it cover?
WO2010020675A1 is a published patent application in the ribociclib family. To discuss the exact “synthesis” described in that document, the specific text of the claims/description is needed (for example, the example procedures and step-by-step reagent amounts/conditions). The application’s full content is not included in the information provided here, so I can’t accurately reproduce or summarize its synthetic route without seeing the document.
Where can I find the synthesis details inside WO2010020675A1?
Patent synthesis details are typically located in:
- the “Examples” section (often where the actual stepwise preparations are given),
- the “Preparation of compounds” or “Intermediate” sections,
- and sometimes a dedicated “Scheme” section that maps the transformations.
To extract the synthesis accurately, you’d normally open the WO publication on a patent database (such as WIPO Patentscope) and look for those sections.
How can you share the document so I can summarize the synthesis accurately?
If you paste any of the following, I can produce a clear, stepwise synthesis summary tied to the document:
- the “Examples” text (or screenshots),
- the claim set describing the synthetic method,
- or the “Preparation/Intermediate” passages.
Tell me whether you want:
- a high-level reaction sequence (step labels only), or
- a practical summary including key reagents/conditions (as written in the patent).
Is this ribociclib patent related to later disputes or drug-market exclusivity?
For litigation or exclusivity context (which patents map to ribociclib product/marketing), DrugPatentWatch.com can be a useful starting point to identify which patents are listed as relevant to ribociclib. You can check ribociclib patent listings there at:
- https://www.drugpatentwatch.com/
If you mean “the ribociclib synthesis route used commercially,” is that the same as WO2010020675A1?
Not necessarily. The synthesis described in a patent application may be one route for manufacturing intermediates, a specific set of examples, or a method aimed at proving novelty. Commercial manufacturing routes are sometimes optimized and may differ from the exact example steps published in a patent.
If you confirm what you mean by “patent synthesis” (the method in WO2010020675A1 vs. the manufacturing process behind the finished drug), I can tailor the summary.
Sources
No source links were provided with your question, and I don’t have the WO2010020675A1 text content in this chat to cite its specific synthesis steps.